Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-16 Sale |
2025-01-17 7:27 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
3,554 | $0.58 | $2,061 | 161,687 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-16 5:25 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
1,791 | $0.63 | $1,128 | 57,171 (Direct) |
View |
| 2025-01-14 Sale |
2025-01-15 9:19 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
1,007 | $0.66 | $665 | 54,688 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-07 5:47 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
8,216 | $1.9836 | $16,298 | 47,757 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 5:20 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
5,025 | $2.71 | $13,618 | 137,018 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:20 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
3,575 | $5.74 | $20,521 | 96,047 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-19 6:19 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
1,982 | $5.92 | $11,733 | 66,427 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 4:31 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
942 | $13.6 | $12,811 | 0 (Direct) |
View |
| 2021-01-19 Sale |
2021-01-20 7:03 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
545 | $21.28 | $11,598 | 47,691 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 7:00 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
247 | $26.76 | $6,610 | 0 (Direct) |
View |
| 2020-06-30 Purchase |
2020-07-06 4:15 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
3,383 | $4.87 | $16,475 | 0 (Direct) |
View |
| 2020-07-02 Sale |
2020-07-06 4:15 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
3,383 | $22.49 | $76,084 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Exercise |
2025-01-17 7:27 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
8,685 | $0 | 161,687 (Direct) |
View |
| 2025-01-15 Option Award |
2025-01-17 7:27 pm |
N/A 2035-01-14 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
91,667 | $0 | 161,687 (Direct) |
View |
| 2025-01-14 Exercise |
2025-01-16 5:25 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
4,783 | $0 | 57,171 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 9:19 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
2,646 | $0 | 54,688 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-07 5:47 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
30,000 | $0 | 47,757 (Direct) |
View |
| 2024-01-13 Exercise |
2024-01-17 5:20 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
12,780 | $0 | 137,018 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:20 pm |
N/A 2034-01-14 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
91,667 | $0 | 137,018 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 5:55 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Chief Accounting Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:20 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
58,208 | $0 | 96,047 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:20 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
10,136 | $0 | 96,047 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 6:19 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
10,706 | $0 | 66,427 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 6:19 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
47,833 | $0 | 66,427 (Direct) |
View |
| 2021-01-15 Tax Withholding |
2021-01-20 7:03 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
289 | $21.09 | 47,691 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 7:03 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
834 | $0 | 47,691 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 7:03 pm |
N/A 2031-01-15 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
45,192 | $0 | 47,691 (Direct) |
View |